stocks logo

IBO

Impact Biomedical Inc
$
0.514
-0.007(-1.340%)
  • Overview
  • Forecast
  • Valuation
Line
Line
|
Candle
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
0.559
Open
0.530
VWAP
0.53
Vol
459.67K
Mkt Cap
6.21M
Low
0.5135
Amount
245.36K
EV/EBITDA(TTM)
--
Total Shares
12.09M
EV
16.21M
EV/OCF(TTM)
--
P/S(TTM)
--
Impact Biomedical Inc. is a human healthcare company and is a wholly owned subsidiary of DSS, Inc. The Company, through the utilization of its intellectual property rights, or through investment in, or through acquisition of companies in the bio health and biomedical fields, focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune related diseases. The Company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. The Company, through its subsidiary, Global BioLife, Inc., focuses on research in four main areas: the Linebacker project, which develops a universal therapeutic drug platform; a new sugar substitute called Laetose; a multi-use fragrance called 3F (Functional Fragrance Formulation), which is a mosquito fragrance product; and Equivir/Nemovir, a blend of natural polyphenols designed as an antimicrobial medication.
Show More

Valuation Metrics

The current forward P/E ratio for Impact Biomedical Inc (IBO.A) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Impact Biomedical Inc 's fair value, click here.

Forward PE

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00

Financials

Annual
Quarterly
FY2024Q4
N/A
Total Revenue
FY2024Q4
YoY :
-23.18%
-875.00K
Operating Profit
FY2024Q4
YoY :
+2051.70%
-27.13M
Net Income after Tax
FY2024Q4
YoY :
+2045.45%
-2.36
EPS - Diluted
FY2024Q4
YoY :
+190.07%
-1.26M
Free Cash Flow
FY2024Q4
N/A
Gross Profit Margin - %
FY2024Q4
N/A
FCF Margin - %
FY2024Q4
N/A
Net Margin - %

Trading Trends

Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
7.3M
USD
11
3-6
Months
58.0
USD
1
6-9
Months
17.0K
USD
3
0-12
Months
0.0
USD
0
Bought
0-3
1
310.0
USD
Months
3-6
0
0.0
USD
Months
6-9
5
159.6K
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months

IBO News & Events

Events Timeline

2025-02-26 (ET)
2025-02-26
08:40:42
Impact BioMedical announces acquisition of Celios in $1.15M equity transaction
select
2025-02-26
08:36:20
DSS announces sale of Celios to Impact BioMedical
select
2024-11-19 (ET)
2024-11-19
07:09:05
Impact BioMedical CEO says 'well-positioned' to drive long-term value
select
Sign Up For More Events

News

2.0
05-05Benzinga
Why Faraday Future Intelligent Electric Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
4.5
05-02Benzinga
S&P 500 Gains 1%; April Jobs Top Expectations
4.5
04-04Benzinga
Dow Tumbles 1,100 Points; US Economy Adds 228,000 Jobs In March
Sign Up For More News

FAQ

arrow icon

What is Impact Biomedical Inc (IBO) stock price today?

The current price of IBO is 0.5139 USD — it has decreased -1.34 % in the last trading day.

arrow icon

What is Impact Biomedical Inc (IBO)'s business?

arrow icon

What is the price predicton of IBO Stock?

arrow icon

What is Impact Biomedical Inc (IBO)'s revenue for the last quarter?

arrow icon

What is Impact Biomedical Inc (IBO)'s earnings per share (EPS) for the last quarter?

arrow icon

What changes have occurred in the market's expectations for Impact Biomedical Inc (IBO)'s fundamentals?

arrow icon

How many employees does Impact Biomedical Inc (IBO). have?

arrow icon

What is Impact Biomedical Inc (IBO) market cap?